Keywords: Child-Turcotte-Pugh; BRTO; balloon-occluded retrograde transvenous obliteration; CTP; Child-Turcotte-Pugh; HE; hepatic encephalopathy; HCC; hepatocellular carcinoma; MELD; model for end-stage liver disease; PARTO; plug-assisted retrograde transvenous obliteration; PSSs; p
مقالات ISI Child-Turcotte-Pugh (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Child-Turcotte-Pugh; AC; alcoholic cirrhosis; BMI; body mass index; CTP; Child-Turcotte-Pugh; DM; diabetes mellitus; HDL; high density lipoprotein; IFG; impaired fasting glucose; MS; metabolic syndrome; NAFLD; nonalcoholic fatty liver disease; TGs; triglycerides; nonalcoh
Keywords: Child-Turcotte-Pugh; BMI; body mass index; CTP; Child-Turcotte-Pugh; HG; handgrip; MAC; mid arm circumference; MAMC; mid arm muscle circumference; SGA; subjective global assessment; TST; triceps skin fold thickness; handgrip; strength; cirrhosis; nutrition;
Keywords: Child-Turcotte-Pugh; Liver Disease; Psychiatric; Variceal Bleeding; Nutrient; CFF; critical flicker frequency; CI; confidence interval; CTP; Child-Turcotte-Pugh; HE; hepatic encephalopathy; HRQOL; health-related quality of life; MELD; model for end-stage liver disease; MH
Keywords: Child-Turcotte-Pugh; CI; confidence interval; CR; complete response; CTP; Child-Turcotte-Pugh; DFS; disease-free survival; HCC; hepatocellular carcinoma; MELD; Model for End-Stage Liver Disease; mRECIST; modified Response Evaluation Criteria In Solid Tumors; SBRT; stereot
Keywords: Child-Turcotte-Pugh; NACSELD; Decompensation; Antibiotic; Complication; CARS; compensatory anti-inflammatory response system; CI; confidence interval; CTP; Child-Turcotte-Pugh; DRO; drug-resistant organism; MELD; model for end-stage liver disease; NACSELD; North American
Impact of Direct Acting Antiviral Drugs in Treatment Naïve HCV Cirrhosis on Fibrosis and Severity of Liver Disease: A Real Life Experience from a Tertiary Care Center of North India
Keywords: Child-Turcotte-Pugh; APRI; AST to Platelet Ratio Index; CTP; Child-Turcotte-Pugh; FIB-4; fibrosis-4; MELD Na; Model for End-Stage Liver Disease sodium; TE; transient elastography; APRI, AST to Platelet Ratio Index; FIB-4, fibrosis-4; CTP, Child-Turcotte-Pugh; MELD Na, Mod
Cone Beam CT-Guided Chemoembolization of Probable Hepatocellular Carcinomas Smaller than 1 cm in Patients at High Risk of Hepatocellular Carcinoma
Keywords: Child-Turcotte-Pugh; CI; confidence interval; CTP; Child-Turcotte-Pugh; DSA; digital subtraction angiography; HCC; hepatocellular carcinoma; HR; hazard ratio; MELD; Model for End-stage Liver Disease; TTLP; time to local progression; TTP; time to progression;
Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis
Keywords: Child-Turcotte-Pugh; Simvastatin; Prognosis; Decompensation; Mortality; BMI; body mass index; CI; confidence interval; CCR; clinical case registry; CTP; Child-Turcotte-Pugh; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HR; hazard ratio; ICD-9; International Clas
Association Between Ratio of Sodium to Potassium in Random Urine Samples and Renal Dysfunction and Mortality in Patients With Decompensated Cirrhosis
Keywords: Child-Turcotte-Pugh; Urine Sodium to Potassium Ratio; Glomerular Filtration Rate; Cirrhosis; Prognosis; MELD Score; AUROC; area under the receiver operating characteristic curve; CI; confidence interval; CTP; Child-Turcotte-Pugh; Cr; serum creatinine; eGFR; estimated glom
Long-term Efficacy and Safety of Lamivudine, Entecavir, and Tenofovir for Treatment of Hepatitis B Virus-Related Cirrhosis
Keywords: Child-Turcotte-Pugh; Liver Function; Varices; Ascites; HCC Incidence; ALT; alanine aminotransferase; CTP; Child-Turcotte-Pugh; HBeAg; hepatitis B e antigen; HBV; hepatitis B virus; MELD; model for end-stage liver disease;
Multivariate Analysis of Prognostic Factors for Survival following Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
Keywords: Child-Turcotte-Pugh; AFP; α-fetoprotein; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; CTP; Child-Turcotte-Pugh; DEB; doxorubicin-eluting bead; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular carcinoma; HR; hazard ratio; INR; International N
Dietary Cholesterol Intake Is Associated With Progression of Liver Disease in Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial
Keywords: Child-Turcotte-Pugh; Diet; Cholesterol; Hepatitis C; Cirrhosis; AHR; adjusted hazard ratio; BMI; body mass index; CI; confidence interval; CTP; Child-Turcotte-Pugh; FFQ; food frequency questionnaire; HALT-C; Hepatitis C Antiviral Long-term Treatment Against Cirrhosis; HCC
Granulocyte Colony-Stimulating Factor Mobilizes CD34+ Cells and Improves Survival of Patients With Acute-on-Chronic Liver Failure
Keywords: Child-Turcotte-Pugh; Liver Regeneration; Liver Stem Cells; Growth Factor; Cirrhosis; ACLF; acute-on-chronic liver failure; CTP; Child-Turcotte-Pugh; G-CSF; granulocyte colony-stimulating factor; HVPG; hepatic venous pressure gradient; MELD; Model for End-Stage Liver Dis
ReviewHepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy
Keywords: Child-Turcotte-Pugh; ADV; adefovir dipivoxil; CHB; chronic hepatitis B; CTP; Child-Turcotte-Pugh; ETV; entecavir; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HDV; hepatiti
Use of Over-the-Counter Analgesics Is Not Associated With Acute Decompensation in Patients With Cirrhosis
Keywords: Child-Turcotte-Pugh; APAP; acetaminophen (N-acetyl-para-aminophenol); AST; aspartate aminotransferase; CTP; Child-Turcotte-Pugh; INR; international normalized ratio; MELD; Model of End-Stage Liver Disease; NSAIDs; nonsteroidal anti-inflammatory drugs; OTCAs; over-the-coun
Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems
Keywords: Child-Turcotte-Pugh; Child-Turcotte-Pugh; End-stage liver disease; Liver cirrhosis; Liver transplantation; MELD; Organ allocation;
Treatment of Hepatitis C in the Patient With Decompensated Cirrhosis
Keywords: Child-Turcotte-Pugh; CTP; Child-Turcotte-Pugh; HALT-C; Hepatitis C Antiviral Long-Term Treatment against Cirrhosis; HCV; hepatitis C virus; MELD; Model for End-Stage Liver Disease; SVR; sustained virologic response;
Evaluation of the increase in model for end-stage liver disease (ÎMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score
Keywords: Child-Turcotte-Pugh; Child-Turcotte-Pugh; International normalized ratio; Liver cirrhosis; Liver transplantation; MELD; ÎMELD; CTP; Child-Turcotte-Pugh; HCC; hepatocellular carcinoma; INR; international normalized ratio; MELD; model for end-stage liver disease; ÎMEL